Citations

Clear

6 citation(s) found for "Kolasa, K".

C78-39 A Mediastinal Mass Mystery: Suspected Thymic Carcinoma With a Twist
Kolasa, K, Egan, A

Mayo Clinic

American Journal of Respiratory and Critical Care Medicine | May 18, 2026 | Volume: 212 | Issue: Supplement_1 | Pages: No page available

10.1093/ajrccm/aamag162.3970 Get It

Abstract When evaluating malignant anterior mediastinal masses, thymic carcinoma and lymphoma represent the most common etiologies. We present a case of a patient with an incidentally found anterior mediastinal mass, initially suspected to be thymic carcinoma, who was ultimately diagnosed with primary mediastinal classical Hodgkin lymphoma. A 55-year-old woman with no contributory past medical history presented to her primary care provider with several weeks of cough which was unresponsive to antibiotics and corticosteroids. A chest x-ray demonstrated a large mediastinal mass and subsequent CT chest further revealed an anterior mediastinal mass measuring 15 x 6 x 13 cm. A PET-CT showed intense FDG uptake in the mediastinal mass (SUVmax 14.5) and FDG-avid right pleural lesions suggestive of metastases (SUVmax 4.5). She was referred to outpatient pulmonary clinic. Given imaging findings, thymic carcinoma was initially favored. Following multidisciplinary discussion with Thoracic Surgery, neoadjuvant chemotherapy was recommended prior to any consideration of surgical resection given the size and involvement of mediastinal structures. Thus, CT-guided biopsy was pursued to confirm the diagnosis, but unexpectedly revealed classical Hodgkin lymphoma of the nodular sclerosis subtype. She was diagnosed with stage IVA disease and urgently initiated chemotherapy with nivolumab, doxorubicin, vinblastine, and dacarbazine (N-AVD). A repeat PET-CT two months after initiation of treatment demonstrated marked metabolic and anatomic response, with the mediastinal mass reduced to 8.9 x 5.4 cm with an SUVmax of 2.1. Similarly, the FDG-avid pleural metastases had a decrease in SUVmax to 1.0. The patient was continued on the same treatment regimen. Although thymic carcinoma was initially suspected, a biopsy was obtained because surgical resection was not planned as the initial step in management. Typically, thymic malignancies are not biopsied prior to surgery due to the risk of tumor seeding and the preference for definitive resection, with some exceptions. In this case, the decision to biopsy resulted in the unexpected diagnosis of primary mediastinal classical Hodgkin lymphoma, a particularly rare entity among anterior mediastinal masses. This case underscores the importance of individualized diagnostic strategies and the role of tissue confirmation when clinical or therapeutic circumstances deviate from standard practices. This abstract is funded by: None
A80-4-37 Incidental Plasmacytoma: An Unusual Presentation of Multiple Myeloma
Kolasa, K, Egan, A

Mayo Clinic

American Journal of Respiratory and Critical Care Medicine | May 18, 2026 | Volume: 212 | Issue: Supplement_1 | Pages: No page available

10.1093/ajrccm/aamag162.3752 Get It

Abstract Plasmacytomas are a form of plasma cell malignancy which can occur as isolated lesions or as part of systemic multiple myeloma. We present a case of a patient whose evaluation for an incidentally found lung mass led to the diagnosis of multiple myeloma. A 65-year-old man with no remarkable past medical history presented to the emergency department with two days of fever, cough, and chills. A chest x-ray demonstrated findings suggestive of pneumonia as well as a “smoothly marginated density in the left lung apex.” CT chest further revealed a destructive mass involving the left third rib measuring 7.6 x 4.6 cm; it was difficult to determine from imaging if the mass originated from the lung, pleura, or bone. PET-CT showed significant FDG avidity of the mass (SUVmax 40.2) and FDG-avid left mediastinal and supraclavicular lymph nodes. He subsequently presented to outpatient pulmonary clinic for further evaluation. Given imaging findings, primary lung malignancy or soft tissue sarcoma was initially suspected. He underwent CT-guided biopsy of the mass with pathology showing a kappa light chain-restricted plasmacytoma. Serum studies demonstrated a markedly elevated kappa/lambda ratio of 132. Bone marrow biopsy confirmed a kappa light chain-restricted plasma cell myeloma with 20% plasma cells. On review of previous labs, the patient was noted to have anemia (hemoglobin 11.9 g/dL) previously attributed to iron deficiency anemia as well as hypercalcemia (10.3 mg/dL). Renal function was normal. He was diagnosed with multiple myeloma and started on daratumumab, bortezomib, lenalidomide, and dexamethasone (Dara-VRD), with favorable response to treatment. The presence of plasmacytomas is clinically important to recognize in multiple myeloma as they are predictors of poorer outcomes. The site of origin also carries prognostic implications: paraskeletal plasmacytomas arising from bone marrow are associated with better outcomes than extramedullary plasmacytomas which result from hematogenous spread. In one study, paraskeletal plasmacytomas were found to occur in 17.6% of patients with multiple myeloma, with 40% located in the chest; similarly, extramedullary plasmacytomas were associated with the lungs or pleura in 23% of patients. Altogether, this case underscores the importance of considering plasmacytomas in the differential of a lung mass, particularly if there is osseous involvement. This abstract is funded by: None
B45-28 Gastroesophageal Reflux Disease Is Associated With Increased Pneumonia, Disease Exacerbations, and Mortality in Non-Cystic Fibrosis Bronchiectasis: A Large Propensity Score-Matched Analysis
Daher, D, Doumat, G, Kolasa, K, Mokahal, A El, Kanj, A N, Daher, Darine , Doumat, George , Mokahal, Ali El , Kanj, A.N.

Mayo Clinic

American Journal of Respiratory and Critical Care Medicine | May 18, 2026 | Volume: 212 | Issue: Supplement_1 | Pages: No page available

10.1093/ajrccm/aamag162.1249 Get It

Abstract Rationale Gastroesophageal reflux disease (GERD) is a common comorbidity in non-cystic fibrosis bronchiectasis (NCFB), yet its impact on clinical outcomes remains poorly defined. We sought to determine whether GERD is associated with worse clinical outcomes in patients with NCFB using a large, real-world database. Methods We conducted a retrospective cohort study using the TriNetX platform, identifying patients with NCFB (ICD-10 J47*) with and without concurrent GERD (ICD-10 K21*), excluding those with cystic fibrosis (ICD-10 E84*). Propensity score matching (PSM) was performed using 1:1 nearest neighbor matching without replacement, controlling for age, sex, race/ethnicity, obesity, socioeconomic risk factors, and tobacco use. Primary outcomes included pneumonia, bronchiectasis exacerbations, intensive care unit admission, mechanical ventilation, and mortality. Statistical analyses included risk ratios and Cox proportional hazards modeling for survival outcomes. Results Out of 421,710 patients with NCFB in the dataset from January 2000 to September 2025, 186,874 (44%) had a diagnosis of GERD. After propensity score matching, 179,753 patients with NCFB+GERD and 179,753 patients with NCFB-only were included (mean age 74.0±13.1 years, 58.8% female, 67.1% White). Baseline characteristics were well-balanced after matching. Median follow-up was approximately 2.5 years for both cohorts (898 vs 889 days; similar means and IQR), ensuring balanced observation time. Compared to NCFB-only, NCFB+GERD was associated with increased risks for mortality (risk ratio 1.04, 95% CI 1.02-1.05; p < 0.001), pneumonia (risk ratio 1.06, 95% CI 1.05-1.08; p < 0.001), bronchiectasis exacerbations (risk ratio 1.03, 95% CI 1.01-1.06; p = 0.006), and mechanical ventilation (risk ratio 1.14, 95% CI 1.10-1.18; p < 0.001). Intensive care unit admission rates were comparable between groups (risk ratio 1.00; p = 0.65). Conclusions In this large propensity score-matched analysis, concurrent GERD in NCFB is independently associated with increased mortality, pneumonia, bronchiectasis exacerbations, and mechanical ventilation requirements. These findings suggest GERD may represent a modifiable risk factor warranting aggressive management in NCFB patients. Study limitations include retrospective design, reliance on ICD-10 coding accuracy, and potential unmeasured confounders. Our results support systematic screening and treatment of GERD in NCFB, but whether targeted GERD management can modify the natural history of NCFB future investigation. This abstract is funded by: None
A Tale of Two (Rare) Illnesses: Fibrosing Mediastinitis, Initially Diagnosed as IgG4-related Disease
Kolasa, Kathryn M. , Egan, Aoife M. , Kolasa, K.

Mayo Clinic

American Journal of Respiratory and Critical Care Medicine | May 11, 2025 | Volume: 211 | Issue: Supplement_1 | Pages: A6681-A6681

10.1164/ajrccm.2025.211.abstracts.a6681 Get It

Abstract Fibrosing mediastinitis is an infiltrative disease which may develop secondary to a variety of causes, including autoimmune, infectious, and malignant processes. Here, we present a case of fibrosing mediastinitis, with initial concerns for IgG4-related disease. A 36-year-old man presented to his primary provider with three months of intermittent dyspnea. CT chest was significant for a large, infiltrative mediastinal and left hilar mass with calcifications and involvement of the left upper and lower lobe bronchi, lingular bronchus, and left main pulmonary artery. Subsequent autoimmune and fungal studies were negative. The patient underwent bronchoscopy, with biopsy of a lymph node at station 11L showing increased IgG4 on immunostain (30 cells/hpf), though IgG immunostaining was not completed for comparison. Despite initial concerns for fibrosing mediastinitis, the patient was diagnosed with IgG4-related disease and initiated on rituximab and mycophenolate. Notably, the patient's serum IgG4 concentrations were consistently within normal limits before and after initiation of rituximab. The patient was referred to our clinic after lack of response to therapy on imaging. Laboratory evaluation redemonstrated a normal serum IgG4 concentration and fungal studies were consistent with previous histoplasma infection, suggesting fibrosing mediastinitis secondary to histoplasmosis. IgG4-related disease was determined to be unlikely considering repeatedly normal IgG4 levels and weakly positive IgG4 staining. Repeat CT chest demonstrated fibrosis of the left upper lobe; compression of the left atrial appendage; and occlusion and severe obstruction of the left superior pulmonary vein and left lower lobe pulmonary artery, respectively. VQ scan demonstrated significantly reduced perfusion of the left lung and the patient was referred for stenting of the affected vasculature. PET-CT revealed moderate FDG avidity of the left hilar nodes, concerning for ongoing active fibrosing mediastinitis, for which he was continued on rituximab. The indolent nature of fibrosing mediastinitis often leads to advanced disease at the time of presentation. Hilar structures are commonly involved, as in the case of this patient with a severe perfusion defect secondary to obstruction of the pulmonary vessels. A diagnosis of fibrosing mediastinitis merits careful investigation of the underlying cause. Fungal infections, specifically histoplasmosis in North America, are a leading cause of this condition. IgG4-related disease is also associated with fibrosing mediastinitis, and both conditions are driven by fibroinflammatory processes. However, it is important to note that IgG4 immunostaining is non-specific, and diagnosis of IgG4-related disease requires the meeting of rigorous criteria. Differentiation between these diagnoses is important given potential differences in management.
Abstract 3229: First Time Validation of Point to Point NavX Map Registration to 3D Subject-Specific Computed Tomography (CT)
Kolasa, Mark, Johnson, Susan B., Olson, Eric, Schweitzer, Jeffrey S. , Packer, Douglas L. , Okumura, Yasuo , Schweitzer, Jeffrey

Mayo Clinic

Circulation | July 3, 2021 | Volume: 116 | Issue: suppl_16 | Pages: No page available

10.1161/circ.116.suppl_16.ii_726-c Get It

Background: Current mapping systems use simultaneous displays of overlapping 3D maps and pre-acquired CT images of the LA to “pseudo-register” data sets rather than specifically “register” each point of one mapping data set to the other. The appropriateness of the 2 data set match has not been validated. Since significant surface to surface mismatch errors may occur, this study was undertaken to quanititatively validate NavX map to CT registration and determine its suitability for guiding AF ablation. Methods: Sixty-four slice, multidetector CT scans were acquired in 8 dogs and segmented to establish subject-specific LA/PV volumes for importation into the EnSite mapping system. A detailed multi-surface geometry (NavX map) was collected by navigating a mapping catheter in target LA and PVs. Using a novel developmental registration algorithm the map was registered to LA/PV CT volume. Validation was performed using the registered 3D CT model for the guidance of ablation at the location of multiple implanted radio-opaque markers. Results: A total of 39 radio-opaque markers were implanted before CT including 9 LSPV, 8 RSPV, 7 RIPV, 9 LIPV, 3 roof, and 3 LAA locations. Subsequent registration of individual NavX maps to acquired 3D CT volume was successfully completed in all animals. RF ablations were performed at the predicted 3D registered model locations of the radio-opaque markers using 5 mm tip RF ablation catheter. Resulting mean lesion size was 5.3 x 6.5 mm. The lesions enveloped the point of marker attachment to the myocardium in 31/36 (86%) ablations. The average distance from the center of the RF lesion to the targeted site was 2.5 ± 1.5mm. 47 points were successfully navigated under fluorscopic and ICE guidance. All points were accurately portrayed on the 3D registered model. 3 points in the region of the RSPV floor did have minor offsets on the model due to technically difficult segmentation of the RSPV from the right pulmonary artery. Conclusion: These data demonstrate the feasibility of registering NavX derived geometries to CT data sets accommodating sources of cardiac, respiratory, and translational cycle dependent error. Catheter navigation precisely conducted using the registered model demonstrates accuracy within the range required for RF ablation.
Abstract 4648: Mechanism of Tissue Cooling With Cryoenergy Delivery to Pulmonary Veins: Tissue Temperature Distribution and Chonic Esophageal Effects
Dalegrave, Charles, Henz, Benhur Davi , Kolasa, Mark, Miller, Dylan V. , Johnson, Susan B., Packer, Douglas L. , Okumura, Yasuo

Mayo Clinic

Circulation | July 3, 2021 | Volume: 118 | Issue: suppl_18 | Pages: No page available

10.1161/circ.118.suppl_18.s_924-a Get It

Background: Although pulmonary vein (PV) isolation has been used to treat AF, complications create important limitations. New energy sources, including cryothermal, have been developed to minimize these complications. The purpose of this study was to evaluate the effect of PV cryoablation on esophageal (ESO) temperatures acutely and correlate them with chronic effects on the esophageal wall. Methods: A 23 mm cryoballoon was placed in the LA of 10 dogs through a 12 Fr deflectable sheath. PV and ESO temperatures (TEMP) were recorded using 7–9 thermocouples (TC) outside the PVs and on the external and internal ESO surfaces during 2 cryoablations of 4 min duration. Results : Cryoablation of 15 PV (10 RIPV and 5 LIPV) during 1.7±0.6 ablations yielded a total of 168 TC time-TEMP profiles (6.4±2.4/PV). Minimum tissue TEMP was inversely dependent on the distance of the TC from the balloon surface (Table 1 ). All PVs were isolated acutely and 14/15 (93%) chronically. Minimum TEMP achieved at the PV surface and external ESO were similar (−32±8 and −37±9 at targets within 2.5 mm from the balloon respectively [P=NS]). A TEMP decrease at the internal ESO was seen during 15 of 25 (60%) ablations, but was significantly less pronounced than the external TEMP (17.9°C±13.3 and 6.1°C±24.8 [p<0.05]) resulting in a minimum recorded internal TEMP of −6.2°C. The ESO histological examination in 5 dogs showed very limited external lesions in these dogs (depth= 2.2±1.1, width3 18.6±7.4 and length= 12±5.7 mm), but no transmural or internal ulceration, fibrosis or scarring seen. Conclusion: Although PV cryoablation decreases external ESO temperature and produces minor lesions, significant chronic disruptive tissue damage was not seen. Esophageal injury is an unlikely, but potential complication of cryoablation, with internal temperature proving unhelpful in predict negative outcome.